In a multivariate Cox analysis that considered age, sex, tumor grade, and tumor stage as confounding factors, patients with high expression of IL-2 mRNA had a hazard ratio (HR) for disease mortality of 0.52 (95% CI 0.33–0.81; p = 0.004; Fig. S1C). This evidence concerns the gene IL2 and neoplasm.